PTGS2 and adenocarcinoma: Moreover, for the genotype distribution of COX-2 –1195G/A, there is no significant difference between lung cancer patients and the controls (p = 0.17), and also no significant difference was obsearved between the adenocarcinoma group and the squamous cell carcinoma group (p = 0.158).